文献速递心脏核医学神经核医学

99mTc-DPD软组织摄取能否识别心脏转甲状腺素蛋白相关淀粉样变性中多发性神经病风险较高的患者

Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?
PubMed 文献 · J Nucl Cardiol · 2022-07-11

该回顾性研究纳入50例心脏转甲状腺素蛋白相关淀粉样变性(cATTR)患者,评估平面全身DPD骨显像及部分患者胸部定量SPECT/CT软组织摄取与多发性神经病(PNP)诊断的关系。结果显示合并PNP者Perugini评分及左腋窝皮下脂肪SUVpeak均显著高于无PNP者。作者认为DPD骨显像可能有助于识别cATTR患者中因软组织摄取增高而存在PNP风险者。

要点

  • 合并PNP的cATTR患者Perugini评分显著高于无PNP者(2.51±0.51 vs 2.13±0.52,P=0.03)。
  • 22例定量SPECT/CT亚组中,合并PNP者左腋窝皮下脂肪DPD摄取SUVpeak显著高于无PNP者(1.36±0.60 vs 0.74±0.52,P=0.04)。
  • 作者认为DPD骨显像可能有助于识别cATTR患者中因软组织摄取增高而存在PNP风险者。

核心结论

  • 本研究提示DPD骨显像可能有助于识别cATTR患者中因DPD软组织摄取增高而存在PNP风险者。

研究设计与样本

  • 回顾性评估50例cATTR患者,均接受平面全身DPD骨显像和神经传导研究(NCS)。
  • 其中22例患者亚组另行胸部定量SPECT/CT,评估左腋窝区域皮下脂肪组织的标准摄取值(SUVpeak)。

主要发现

  • 合并PNP的cATTR患者Perugini评分显著高于无PNP者(2.51±0.51 vs 2.13±0.52;P=0.03)。
  • 定量SPECT/CT显示合并PNP的cATTR患者左腋窝皮下脂肪DPD摄取显著高于无PNP者(1.36±0.60 vs 0.74±0.52;P=0.04)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With the introduction of several drugs for the therapy of transthyretin-related amyloidosis (ATTR) which slow down the disease, early detection of polyneuropathy (PNP) is becoming increasingly of interest. [99mTc]-3,3-Diphosphono-1,2-Propanodicarboxylic Acid (DPD) bone scintigraphy, which is used for the diagnosis of cardiac (c)ATTR, can possibly make an important contribution in the identification of patients at risk for PNP. METHODS: Fifty patients with cATTR, who underwent both planar whole-body DPD scintigraphy and nerve conduction studies (NCS) were retrospectively evaluated. A subgroup of 22 patients also underwent quantitative SPECT/CT of the thorax from which Standardized Uptake Values (SUVpeak) in the subcutaneous fat tissue of the left axillar region were evaluated. RESULTS: The Perugini score was significantly increased in patients with cATTR and additional diagnosis of PNP compared to patients without (2.51 ± 0.51 vs 2.13 ± 0.52; P = 0.03). Quantitative SPECT/CT revealed that DPD uptake in the subcutaneous fat of the left axillar region was significantly increased in cATTR patients with compared to patients without (1.36 ± 0.60 vs 0.74 ± 0.52; P = 0.04). CONCLUSION: This study suggests that DPD bone scintigraphy is a useful tool for identification of patients with cATTR and a risk for PNP due to increased DPD soft tissue uptake.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Wollenweber T, Kretschmer-Chott E, Wurm R, et al. Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy? J Nucl Cardiol. 2022. PMID: 35817943. doi:10.1007/s12350-022-02986-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。